TheEdgeResearch
Home / Stocks / SPLIF

High Fusion Inc. (SPLIF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00
Market Cap
$767,564
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.31
52-Wk Range
CEO
William Gillespie
Country
CA
Currency
USD

High Fusion Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, giving a market capitalisation of $767,564. On trailing twelve-month figures it carries a net margin of -330.3%. Its beta of 0.31 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
0.00
Gross margin
20.0%
Operating margin
-143.0%
Net margin
-330.3%
Return on equity
Debt / equity
-1.84
Current ratio
0.28
Dividend yield
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2015-04-28
Headquarters
Toronto, ON, CA
About High Fusion Inc.

Founded in 2004 and based in Toronto, Canada, High Fusion Inc. is dedicated to crafting and producing branded cannabis items. The company primarily concentrates on offerings like flower, pre-rolls, vapes, edibles, and oil extracts, intended for both medical and adult recreational users across the United States. Its array of brands includes FLÏ (recognized for edibles and vape products), OutCo, and Thrive. The corporation transitioned its name to High Fusion Inc. in November 2021, having previously operated under the name Nutritional High International Inc.

Comparable companies

High Fusion Inc. is most often compared with the following Healthcare names:

GNOWHCYTDLTTSFNBGVPCNTPRXTFSBUDFSEPSFSLGWFVEGGD
More research on SPLIF
SPLIF technical analysis SPLIF TheEdge Score Compare against peers
Open full interactive analysis & DCF →